Abbott Structural Heart

A FRESH PERSPECTIVE

Abbott Structural Heart

Abbott is at the forefront of transforming structural heart therapies, leading the development of more advanced solutions for patient care. As a passionate, committed, and innovative group of people with a fresh perspective, we strive to be your best partner—so that you achieve successful outcomes and empower lives filled with potential.

Our Mission

CHANGING THE COURSE OF HEART DISEASE

Heart disease is a growing burden worldwide. Statistics reveal that an increasing population, as well as an aging population, will continue to create more urgent patient needs.

The prevalence of valve diseases in the U.S. is 2.5%1
Worldwide, there will be ≃ 1.5 billion people age 65+ by 2050—up from 524 million in 20102
And 50% of people age 65+ can have undiagnosed valvular heart disease3
Worldwide, cardiovascular disease (CVD) is the #1 cause of death, and CVD deaths will increase to 23.6 million annually by 20304,5

Yet we, at Abbott, see the individuals behind the numbers. Every single patient, caregiver, and outcome counts. That is what drives us to create life-changing technologies that restore health and improve quality of life, unlocking every heart’s potential.

Our Vision

LIFE-CHANGING TECHNOLOGIES THAT TRANSFORM FUTURES

From transcatheter and surgical valves to structural interventions, the Abbott Structural Heart portfolio spans a wide range of life-changing technologies. Our vision and leadership in mitral and tricuspid solutions enable us to push the boundaries in developing solutions for undertreated conditions. Moreover the depth and breadth of our experience—paired with our proven therapy solutions—provide the means to help you address structural heart patient needs at every stage of living.

Pioneering transcatheter mitral valve therapies

Read more

Leading structural intervention with the broadest portfolio

Read more

Providing our expertise in surgical valve technologies

Read more

Training and Support

A PARTNERSHIP IN EXCELLENCE

We partner with healthcare providers to deliver unmatched training and support, lending our clinical insights into patient selection, echocardiography and diagnostics, device therapies, and procedural details. All to help physicians deliver the full potential of every Abbott technology.

contact us to learn more

Procedural Training

Our team of clinical experts are with your staff for every training procedure, committed to consistency and safety each step of the way.


 

Procedural Training

Our team of clinical experts are with your staff for every training procedure, committed to consistency and safety each step of the way.

IMAGING EXPERTISE

As transcatheter valve therapies advance, so do imaging technologies – and with them, the need for a trusted partner. Our proctors are highly trained to support your team’s imaging efforts, and have the deep procedural experience to help troubleshoot any scenario.

Ongoing Support

From the robust initial training new centers undergo, to proctoring and case monitoring, and supplementary training offerings, our support enables your continued growth in efficiency and outcomes from day one and beyond.
 

Ongoing Support

From the robust initial training new centers undergo, to proctoring and case monitoring, and supplementary training offerings, our support enables your continued growth in efficiency and outcomes from day one and beyond.

AP2947147-WBU Rev. A

References
  1. Benjamin EJ, et al. Heart disease and stroke statistics—2018 update: a report from the American Heart Association. Circulation. 2018;137(12):e67-e492. doi: 10.1161/CIR.0000000000000558.
  2. World Health Organization and National Institutes of Health. Global health and aging. 2011.
  3. d'Arcy JL, et al. Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: the OxVALVE Population Cohort Study. Eur Heart J. 2016;37:3515–3522. doi:10.1093/eurheartj/ehw229.
  4. World Health Organization. Cardiovascular disease. www.who.int/cardiovascular_diseases/about_cvd/en/. Accessed November 12, 2018.
  5. Mozaffarian D, et al. Heart Disease and Stroke Statistics—2015 Update: a report from the American Heart Association. Circulation. 2015;131:e29-e322. doi: 10.1161/CIR.0000000000000152.
     

This site uses cookies to improve your experience.

To find out more please read our Privacy and Cookies policy.

Ok

YOU ARE ABOUT TO LEAVE
www.structural­heart­solutions.com

You are now leaving www.structuralheartsolutions.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.